Hormonal Changes and Cardiovascular Risk in Women

Cardiovascular disease is the leading cause of death in women globally, yet it remains significantly underdiagnosed and undertreated in this population. One of the central reasons is that women's cardiovascular risk profile is shaped by hormonal factors that have no equivalent in men, and these factors are not always given adequate weight in clinical assessment.

Hormonal changes across a woman's life, from the reproductive years through perimenopause and into postmenopause, have direct and measurable effects on the cardiovascular system. Understanding these mechanisms is essential for healthcare professionals who want to identify risk earlier, interpret symptoms more accurately, and deliver more personalised preventive care.

The Protective Role of Oestrogen

During the reproductive years, oestrogen exerts a broadly protective effect on the cardiovascular system. It supports endothelial function, helping blood vessels maintain flexibility and respond appropriately to changes in blood flow. It contributes to favourable lipid profiles by keeping LDL cholesterol lower and HDL cholesterol higher. It also has anti-inflammatory properties and plays a role in regulating blood pressure.

The result is that premenopausal women, on average, have a lower cardiovascular risk than men of the same age. This protective effect is real, but it can create a false sense of security, both in patients and clinicians. The protection is not permanent, and the transition out of it can be rapid.

How Hormonal Changes During Menopause Elevate Cardiovascular Risk

As oestrogen levels decline during perimenopause and menopause, the cardiovascular protection it provided diminishes. Several risk factors emerge or accelerate during this period:

• Blood pressure: Hypertension becomes significantly more prevalent after menopause. Oestrogen loss affects the renin-angiotensin-aldosterone system and reduces vascular compliance, both of which contribute to rising blood pressure.

• Lipid profile: LDL cholesterol tends to increase while HDL cholesterol decreases, shifting the lipid balance in a less favourable direction.

• Vascular function: Endothelial function declines, increasing arterial stiffness and the risk of atherosclerosis.

• Inflammation: Postmenopausal women show higher levels of systemic inflammatory markers, which are associated with increased cardiovascular risk.

• Body composition: Oestrogen loss is linked to increased visceral fat accumulation and reduced muscle mass, both of which independently elevate cardiovascular risk.

• Heart rhythm: The prevalence of atrial fibrillation increases after menopause, adding stroke risk to an already more complex cardiovascular profile.

Taken together, these changes mean that a woman's cardiovascular risk can shift substantially within a relatively short period. The menopausal transition is not a gradual, linear process; for many women, risk factors emerge and compound quickly.

Beyond Menopause: Other Hormonal Risk Windows

Menopause is the most widely recognised hormonal risk period, but it is not the only one. Several other hormonal contexts across a woman's life are associated with elevated long-term cardiovascular risk and deserve clinical attention:

• Pregnancy complications: Conditions such as pre-eclampsia, gestational hypertension, and gestational diabetes are not only pregnancy risks; they are independent predictors of future cardiovascular disease. Women who experience these complications should be considered at elevated long-term risk and followed up accordingly.

• Polycystic ovary syndrome (PCOS): Associated with insulin resistance, dyslipidaemia, and hypertension, PCOS is increasingly recognised as a cardiovascular risk factor in younger women.

• Early or premature menopause: Women who experience menopause before the age of 40 have a significantly higher risk of cardiovascular disease and all-cause mortality than those who reach menopause at the typical age. This group warrants particularly proactive monitoring.

Why Women's Cardiovascular Risk Is Often Underdiagnosed

Two factors contribute significantly to the underdiagnosis of cardiovascular disease in women. First, women are more likely to present with atypical symptoms. While chest pain is the most recognised sign of a cardiac event, women more frequently report fatigue, shortness of breath, nausea, or discomfort in the back or jaw. These presentations are more easily attributed to other causes, leading to delays in diagnosis and treatment.

Second, much of the foundational cardiovascular research has historically been conducted predominantly in male populations. Risk scores, diagnostic thresholds, and treatment protocols developed from this evidence base may not translate equally well to women. Awareness of this gap is the first step towards addressing it.

What Clinicians Can Do

Healthcare professionals are well positioned to close the gap in women's cardiovascular care. Practical steps include:

• Incorporating hormonal history into cardiovascular risk assessment: Pregnancy complications, age at menopause, and conditions such as PCOS should be documented and factored into risk stratification.

• Monitoring blood pressure closely around the menopausal transition: This is often the earliest measurable cardiovascular change and an important intervention point. Home blood pressure monitoring plays a valuable role here, as readings taken in a familiar environment tend to reflect everyday levels more accurately than clinic measurements alone. Regular home monitoring helps identify trends over time, supports earlier detection of hypertension, and allows patients and clinicians to assess how well treatment or lifestyle changes are working. It also facilitates more informed clinical conversations by providing reliable, real-world data ahead of appointments.

• Assessing lipid profiles and body composition at and after menopause, with attention to visceral fat rather than body weight alone.

• Educating patients on symptom recognition: Women should be informed that cardiovascular symptoms may not match the classic presentation and encouraged to seek assessment for any unexplained or persistent symptoms. A helpful resource to support this conversation is OMRON's awareness leaflet on menopause, blood pressure, and cardiovascular risk, available to download from the professional website at omron-healthcare.com/professional/downloads-for-healthcare-professionals.

• Supporting lifestyle interventions tailored to the menopausal context, including dietary guidance, physical activity recommendations that incorporate resistance training, and stress management strategies.

Conclusion

Hormonal changes across a woman's life have a profound and often underappreciated impact on cardiovascular health. Oestrogen's protective role during the reproductive years gives way to a more complex and elevated risk profile as levels decline, and this shift requires proactive clinical attention. By understanding the mechanisms involved and incorporating hormonal history into routine cardiovascular assessment, healthcare professionals can identify risk earlier and intervene more effectively.

For clinicians looking to deepen their understanding of the relationship between menopause, blood pressure, and cardiovascular risk, the OMRON Academy offers an in-depth course dedicated to this topic: "Menopause, Blood Pressure and Cardiovascular Risk." The course provides a detailed clinical foundation to support more informed, evidence-based care for women in this life stage.

Explore the course at academy.omron-healthcare.com

This content has been reviewed and approved by a cross-functional team at Omron Healthcare Europe to ensure the accuracy of the information provided. Approval Code: OHEAPP-1130